Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Endosc. Dec 16, 2013; 5(12): 600-604
Published online Dec 16, 2013. doi: 10.4253/wjge.v5.i12.600
Published online Dec 16, 2013. doi: 10.4253/wjge.v5.i12.600
Repeat endoscopic submucosal dissection for recurrent gastric cancers after endoscopic submucosal dissection
Yuto Shimamura, Naoki Ishii, Kaoru Nakano, Takashi Ikeya, Kenji Nakamura, Koichi Takagi, Katsuyuki Fukuda, Yoshiyuki Fujita, Department of Gastroenterology, St. Luke’s International Hospital, Tokyo 104-8560, Japan
Koyu Suzuki, Department of Pathology, St. Luke’s International Hospital, Tokyo 104-8560, Japan
Author contributions: Shimamura Y and Ishii N contributed equally to this work; Shimamura Y and Ishii N designed and performed the research, and wrote the manuscript; Nakano K, Ikeya T, Nakamura K, Takagi K, Fukuda K, Suzuki K and Fujita Y contributed new reagents/analytic tools; Shimamura Y, Ishii N and Suzuki K analyzed the data.
Correspondence to: Yuto Shimamura, MD, Department of Gastroenterology, St. Luke’s International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo 104-8560, Japan. yutshi@luke.or.jp
Telephone: +81-3-35415151 Fax: +81-3-35440649
Received: September 30, 2013
Revised: November 22, 2013
Accepted: December 9, 2013
Published online: December 16, 2013
Revised: November 22, 2013
Accepted: December 9, 2013
Published online: December 16, 2013
Core Tip
Core tip: Although endoscopic submucosal dissection (ESD) is widely accepted as one of the standard treatments for early gastric cancers, there are few reports on re-ESD in the literature. This study clarifies that re-ESD is a safe and effective endoscopic treatment for locally recurrent gastric cancers after ESD.